In an effort to guarantee "the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
23h
HHS Secretary Robert F. Kennedy Jr. discussed a new initiative aimed at improving the safety and nutritional value of baby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback